Vitamin D Levels in Umbilical Cord and It's Impact on Infant and Children's Health (VITADi Study)
VITADi
1 other identifier
observational
100
1 country
1
Brief Summary
This study is a cohort study that aims to assess the relationship between Vitamin D Levels in infant and the risk of anemia, atopic dermatitis, diarrhea and cardiovascular disorders in newborn. The subjects of this study are 100 women who met the inclusion criteria, which are in their third trimester of pregnancy and agree to be included in this study. These subjects then will be examined for their weight using standardized CEBA digital scale, height, upper arm circumference, and blood sampling will also be done to these women to measure their vitamin D levels, calcium, parathyroid hormone, ferritin, Fe serum, IL-16, IL-10. When subjects give birth, the babies will also be included in this study. Anthropometric examination will also be done on the babies, to measure their birth weight, birth length, and head circumference. Blood samples will also be taken from their umbilical cord to assess their complete blood count, ferritin, Fe serum, vitamin D levels, vitamin D receptors, IL-6 and IL-10. All subjects then will be monitored, and home visits will be done when the babies reach 3 months old and 6 months old. An assessment of the incidence of diarrhea, atopic dermatitis, and an assessment of cardiovascular disorders (checking pulse and blood pressure) will be carried out during the visit. At the end of the study, venous blood sampling will be taken to see levels of vitamin D, calcium, parathyroid hormone, routine complete blood count, serum Fe, and ferritin, then data analysis is performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2022
CompletedFirst Submitted
Initial submission to the registry
June 11, 2022
CompletedFirst Posted
Study publicly available on registry
June 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedJune 30, 2022
June 1, 2022
9 months
June 11, 2022
June 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vitamin D Levels
Measured by blood sample collection
August 2022 - February 2023
Secondary Outcomes (5)
Hemoglobin levels
August 2022 - February 2023
IgE
August 2022 - February 2023
Atopic Dermatitis
August 2022 - February 2023
Diarrhea
August 2022 - February 2023
Hypertension
August 2022 - February 2023
Study Arms (2)
Pregnant Women
Women in third semester of pregnancy who are willing to include their babies as samples for the next study, no history of abortion, and not suffering from hypertension and preeclampsia.
Infants
Babies born from mothers who are willing to be included in the study, aterm, with birth weight more than 2500 grams. No congenital abnormalities at birth and no acute infection at birth.
Interventions
Weight, length, upper arm circumference
birth weight, length, head circumference, nutritional status
3 ml of blood will be taken, 1,5 ml each to measure the complete blood count, and other 1,5 ml to measure ferritin, Fe serum, vitamin D levels, vitamin D receptors, IL-6 and IL-10.
Eligibility Criteria
Women in third trimester of pregnancy in Makassar, Surabaya, Mataram who are selected during the screening test.
You may qualify if:
- Women in third trimester of pregnancy
- Agree to include their babies in this study
You may not qualify if:
- History of abortion
- Suffering from hypertension or preeclampsia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hasanuddin University
Makassar, South Sulawesi, 90245, Indonesia
Related Links
- Atkinson, MA, Melamed, ML, Kumar, J., Roy, CN, Miller, ER, 3rd, Furth, SL, \& Fadrowski, JJ (2014). Vitamin D, race, and risk for anemia in children. The Journal of pediatrics, 164(1), 153-158.e1.
- Cadario, F., Savastio, S., Pozzi, E., Capelli, A., Dondi, E., Gatto, M., Zaffaroni, M., \& Bona, G. (2013). Vitamin D status in cord blood and newborns: Ethnic differences. Italian Journal of Pediatrics, 39(1).
- Cyprian, F., Lefkou, E., Varoudi, K., \& Girardi, G. (2019). Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond. Frontiers in Immunology, 10.
Biospecimen
whole blood
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sri Hardiyanti Putri, MD
Hasanuddin University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Pediatrician, Teaching Staff at Pediatric Department Hasanuddin University
Study Record Dates
First Submitted
June 11, 2022
First Posted
June 15, 2022
Study Start
May 15, 2022
Primary Completion
February 1, 2023
Study Completion
March 1, 2023
Last Updated
June 30, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- 6 months after publication
- Access Criteria
- The data will be shared by email sent by the primary investigator
We are going to share individual participant data that underlie results in this publication